Bleomycin electrosclerotherapy in therapy-resistant venous malformations of the body

Wohlgemuth, Walter A.; Mueller-Wille, Rene; Meyer, Lutz; Wildgruber, Moritz; Guntau, Moritz; Heydt, Susanne von der; Pech, Maciej; Zanasi, Alessandro; Floether, Lilit und Brill, Richard (2021): Bleomycin electrosclerotherapy in therapy-resistant venous malformations of the body. In: Journal of Vascular Surgery-Venous and Lymphatic Disorders, Bd. 9, Nr. 3: S. 731-739

Abstract

Objective: Bleomycin is one of the most commonly used agents in sclerotherapy for slow-flow vascular malformations worldwide. However, its efficiency remains unknown. The objective of the present study was to assess whether reversible electroporation combined with bleomycin would increase the sclerotherapy effect in patients with previously unsuccessfully treated venous malformations (VMs). Methods: We performed, to the best of our knowledge, the first retrospective observational case series from January 2019 to January 2020 of 17 patients (20 lesions) with symptomatic VMs, who had previously undergone at least two unsuccessful invasive treatments. Reversible electroporation was performed with various electrodes and directly injected bleomycin. All patient records, magnetic resonance imaging data, documentation of previous treatments, and data regarding the intervention, complications, and clinical symptoms were analyzed. Results: The 17 VM patients (mean age, 20.8 +/- 8.2 years;9 females) had previously undergone an average of 4.2 invasive treatments. These patients had subsequently undergone 22 electrosclerotherapy sessions of 20 lesions. The median dose of bleomycin was 3 mg. The median magnetic resonance imaging-derived lesion volume before treatment was 24.9 cm(3), which had decreased by 86% to 3.5 cm(3) after treatment. After 3.7 months, eight patients were asymptomatic without residual symptoms and nine patients showed improvement. Conclusions: Bleomycin electrosclerotherapy appears to be an effective therapy for patients with VMs resistive to previous invasive therapy. Because of the small sample size and short follow-up period, our results should be examined further using a larger patient population.

• Dokumententyp: Zeitschriftenartikel
• Fakultät: Medizin
• Themengebiete: 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit
• ISSN: 2213-333X
• Sprache: Englisch